Croup Clinical Trial
Official title:
Using a Single Dose of Dexamethasone at 0.6mg/kg of Body Weight Versus 0.15 mg/kg of Body Weight for the Treatment of Croup: an Internal Vanguard Randomized Controlled Non-Inferiority Trial.
Croup is a common childhood respiratory disease that often leads to frequent emergency department visits. It is a viral infection that causes cough, throat, and airway swelling, making breathing difficult. Dexamethasone is a medication that helps to reduce swelling, making breathing easier for children. A standard dose of 0.6mg/kg is used in children. However, a lower amount (due to side effects of steroids in children) has been suggested. We will examine whether 25% less than the standard dose is equally effective in treating croup. Investigators will conduct a clinical study with the support of patients with lived experience (which, in this case, are the parents of the children) to better care for children with croup. If proven, this study can improve the outcome in children with croup.
Croup is a common childhood respiratory disease that leads to frequent emergency department (ED) visits. It accounts for 7% and 3% of hospitalization in under 5 and children between 6 months-3 years in North America, respectively. It is a self-limiting viral infection characterized by the sudden onset of a seal-like barking cough, often accompanied by stridor, voice hoarseness, and respiratory distress. Glucocorticoids are a class of corticosteroids with anti-inflammatory properties that help alleviate croup symptoms. While dexamethasone (a type of glucocorticoid) is commonly used to treat croup at 0.6mg/kg, a low dose of 0.15mg/kg (due to adverse events (AEs)) has been suggested to be equally effective. Investigators propose an innovative and multidisciplinary approach to investigate the noninferiority of dexamethasone at 0.15mg/kg versus 0.6mg/kg to treat croup. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01748162 -
Management of Recurrent Croup
|
Phase 3 | |
| Completed |
NCT00230841 -
Comparing Different Ways of Delivering Humidity to Children With Croup
|
Phase 2 | |
| Terminated |
NCT00147849 -
A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup
|
N/A | |
| Terminated |
NCT03705273 -
Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup
|
Phase 4 | |
| Completed |
NCT01042145 -
Community Care for Croup (RCT)
|
Phase 4 | |
| Completed |
NCT00368823 -
A Trial of Point of Care Information in Ambulatory Pediatrics
|
Phase 3 | |
| Completed |
NCT05668364 -
Impact of Cold Air Exposure on Croup Symptoms
|
N/A | |
| Completed |
NCT03392363 -
Diagnosing Respiratory Disease in Children Using Cough Sounds 2
|
||
| Recruiting |
NCT01664507 -
The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
|
Phase 4 | |
| Completed |
NCT06156436 -
A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department
|
||
| Not yet recruiting |
NCT04168554 -
Telemedicine in the Generals Practitioners Office
|
||
| Completed |
NCT02973282 -
Diagnosing Respiratory Disease in Children Using Cough Sounds
|
N/A | |
| Terminated |
NCT00938353 -
Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup
|
Phase 3 |